Prevalence of Transmitted Antiretroviral Resistance and Distribution of HIV-1 Subtypes Among Patients with Recent Infection in Catalonia (Spain) between 2003 and 2005


Por: Romero, A, Sued, O, Esteve, A, Pumarola, T, Casabona, J, Gonzalez, V, Matas, L, Tural, C, Rodrigo, I, Margall, N, Domingo, P, Casanova, A, Ferrer, E, Caballero, E, Ribera, E, Farre, J, Puig, T, Amengual, MJ, Navarro, G, Prat, JM, Masabeu, A, Simo, JM, Villaverde, CA, Barrufet, P, Sauca, MG, Ortin, X, Orti, A, Navarro, R, Euras, JM, Vilaro, J, Villa, MC, Montull, S, Vilanova, C, Pujol, F, Diaz, O, Miro, JM

Publicada: 1 ago 2011
Resumen:
Objectives: The objectives of this study were to assess the prevalence of transmitted HIV-1 drug resistances (TDR) and HIV-1 subtypes in recently infected patients in Catalonia between 2003 and 2005 and to describe the characteristics of these patients according to the presence or absence of TDR and HIV-1 subtype. Methods: After application of the Serological Testing Algorithm for Recent HIV Seroconversion (STARHS), residual aliquots of serum samples from recently infected antiretroviral-naive individuals were genotyped. FASTA sequences were analyzed using the HIVDB Program. The World Health Organization 2009 List of Mutations for Surveillance of Transmitted HIV-1 Drug Resistant HIV Strains was used to estimate the prevalence of TDR. Results: Of 182 recently infected patients, 14(7.7%) presented TDR. Seven (3.8%) had genotypic evidence of TDR against non-nucleoside reverse transcriptase inhibitors, 6(3.3%) against nucleoside reverse transcriptase inhibitors, 3 (1.6%) against protease inhibitors (Pis), and only 2 individuals (1.1%) presented TDR against more than one class of drugs. Thirty-five (19.2%) patients were infected with a non-B HIV-1 subtype. Conclusion: This is the first study to estimate the prevalence of TDR in recently infected patients in Catalonia. The results are similar to those of studies performed in other Spanish regions. Correct monitoring of these parameters requires systematic epidemiologic surveillance of transmitted resistance. (C) 2010 Elsevier Espana, S.L. All rights reserved.

Filiaciones:
Romero, A:
 Ctr Epidemiol Studies HIV AIDS & STI Catalonia CE, Inst Catala & Oncol, Dept Hlth, Generalitat De Catalunya, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Autonoma Barcelona, Dept Paediat Obstet & Gynaecol, E-08193 Barcelona, Spain

 IMIM Parc Salut Mar, Dept Epidemiol & Evaluat, Barcelona, Spain

Sued, O:
 Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain

Esteve, A:
 Ctr Epidemiol Studies HIV AIDS & STI Catalonia CE, Inst Catala & Oncol, Dept Hlth, Generalitat De Catalunya, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

Pumarola, T:
 Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain

Casabona, J:
 Ctr Epidemiol Studies HIV AIDS & STI Catalonia CE, Inst Catala & Oncol, Dept Hlth, Generalitat De Catalunya, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Autonoma Barcelona, Dept Paediat Obstet & Gynaecol, E-08193 Barcelona, Spain

 IMIM Parc Salut Mar, Dept Epidemiol & Evaluat, Barcelona, Spain

Gonzalez, V:
 Ctr Epidemiol Studies HIV AIDS & STI Catalonia CE, Inst Catala & Oncol, Dept Hlth, Generalitat De Catalunya, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

 Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Genet & Microbiol, Microbiol Serv, Badalona, Spain

Matas, L:
 Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Genet & Microbiol, Microbiol Serv, Badalona, Spain

Rodrigo, I:
 Lab Clin Manso, Barcelona, Spain

Margall, N:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Domingo, P:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Casanova, A:
 Hosp Univ Bellvitge, IDIBELL, Lhospitalet De Llobregat, Spain

Ferrer, E:
 Hosp Univ Bellvitge, IDIBELL, Lhospitalet De Llobregat, Spain

Caballero, E:
 Univ Autonoma Barcelona, Hosp Univ Vall dHebron, E-08193 Barcelona, Spain

Ribera, E:
 Univ Autonoma Barcelona, Hosp Univ Vall dHebron, E-08193 Barcelona, Spain

Farre, J:
 Hosp Arnau Vilanova, Lleida, Spain

Puig, T:
 Inst Recerca SIDA irsiCaixa, Badalona, Spain

 Hosp Arnau Vilanova, Lleida, Spain

Amengual, MJ:
 Univ Autonoma Barcelona, Univ Parc Tauli, Sabadell, Spain

 Univ Autonoma Barcelona, Corp Sanitaria, Sabadell, Spain

Navarro, G:
 Univ Autonoma Barcelona, Univ Parc Tauli, Sabadell, Spain

 Univ Autonoma Barcelona, Corp Sanitaria, Sabadell, Spain

Prat, JM:
 Hosp Palamos, Palamos, Spain

Masabeu, A:
 Hosp Palamos, Palamos, Spain

Simo, JM:
 Hosp Univ St Joan Reus, Reus, Spain

Villaverde, CA:
 Hosp Univ St Joan Reus, Reus, Spain

Barrufet, P:
 Hosp Mataro, Mataro, Spain

Sauca, MG:
 Hosp Mataro, Mataro, Spain

Ortin, X:
 Hosp Tortosa Verge Cinta, Tortosa, Spain

Orti, A:
 Hosp Tortosa Verge Cinta, Tortosa, Spain

Euras, JM:
 Hosp Gen Vic, Vic, Spain

Vilaro, J:
 Hosp Gen Vic, Vic, Spain

Villa, MC:
 Hosp Gen Granollers, Granollers, Spain

Montull, S:
 Hosp Gen Granollers, Granollers, Spain

Pujol, F:
 Projecte Dels Noms Hispanosida, Barcelona, Spain

Diaz, O:
 SAPS Creu Raja, Barcelona, Spain

Miro, JM:
 Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain

Lab Clin Cornella de Llobregat, Cornella De Llobregat, Spain.
ISSN: 0213005X





ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Editorial
EDICIONES DOYMA S A, TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN, España
Tipo de documento: Article
Volumen: 29 Número: 7
Páginas: 482-489
WOS Id: 000294659000002
ID de PubMed: 21543135

MÉTRICAS